Correlation Between Richmond Vanadium and Bio Gene

Can any of the company-specific risk be diversified away by investing in both Richmond Vanadium and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Richmond Vanadium and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Richmond Vanadium Technology and Bio Gene Technology, you can compare the effects of market volatilities on Richmond Vanadium and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Richmond Vanadium with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Richmond Vanadium and Bio Gene.

Diversification Opportunities for Richmond Vanadium and Bio Gene

0.79

Correlation Coefficient

Richmond Vanadium  Bio Gene

Poor diversification

The 3 months correlation between Richmond and Bio is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Richmond Vanadium Technology and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Richmond Vanadium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Richmond Vanadium Technology are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Richmond Vanadium i.e., Richmond Vanadium and Bio Gene go up and down completely randomly.

Pair Corralation between Richmond Vanadium and Bio Gene

Assuming the 90 days trading horizon Richmond Vanadium Technology is expected to generate 0.99 times more return on investment than Bio Gene. However, Richmond Vanadium Technology is 1.01 times less risky than Bio Gene. It trades about 0.02 of its potential returns per unit of risk. Bio Gene Technology is currently generating about -0.02 per unit of risk. If you would invest  22.00  in Richmond Vanadium Technology on September 26, 2024 and sell it today you would lose (1.00) from holding Richmond Vanadium Technology or give up 4.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Richmond Vanadium Technology  vs.  Bio Gene Technology

Richmond Vanadium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Richmond Vanadium Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Bio Gene Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Richmond Vanadium and Bio Gene

The main advantage of trading using opposite Richmond Vanadium and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Richmond Vanadium position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.

The idea behind Richmond Vanadium Technology and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.